surmount-1 trial tirzepatide non-diabetic weight loss after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 SURMOUNT-3: Tirzepatide shows total mean

However, semaglutide has FDA-approved uses under specific brand names and indications, while retatrutide remains investigational

This means your body continues to defend a higher weight set point, making further weight loss mechanically harder

Your 10mg dose remains 10mg of tirzepatide, with B12 added as a supplementary component

This observation is clinically meaningful, as visual disturbances impact daily functioning and quality of life 28

However, the bubble means you received slightly less tirzepatide than intended because the air occupied space that should have contained medication

Tirzepatide works by reducing your appetite, helping you to feel fuller for longer